Latanoprost/timolol
From Infogalactic: the planetary knowledge core
| Combination of | |
|---|---|
| Latanoprost | Prostaglandin |
| Timolol | Beta blocker |
| Clinical data | |
| Trade names | Xalacom |
| AHFS/Drugs.com | UK Drug Information |
| Routes of administration |
Eye drops |
| Identifiers | |
| CAS Number | 852336-82-4 |
| ATC code | S01ED51 (WHO) |
| PubChem | CID: 56841581 |
Latanoprost/timolol (trade name Xalacom) is a combination drug used in glaucoma, consisting of latanoprost (increasing the outflow of aqueous fluid from the eyes (through the uveal-scleral tract[1]) and timolol (a beta blocker decreasing the production of aqueous fluid).
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Drugs that are a combination of chemicals
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Ophthalmology drugs
- Combination drugs
- Pharmacology stubs
